Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: December 2015

PeriRx Investigates Salivary Tests for Lung Cancer

12.08.15 PeriRx Investigates Salivary Tests for Lung CancerOral cancer kills more than 8,650 people each year in the United States, largely due to late diagnosis. PeriRx aims to fight those numbers with its SaliMark OSCC salivary test, which catches cancer in its earliest stages. Now the company has set its experience in salivary diagnoses on a larger target with much more at stake—lung cancer and the more than 150,ooo people it kills each year. [Read more…]

A dental guide to cross-coding for oral cancer screening

12.08.15 - A dental guide to cross-coding for oral cancer screening (DENTAL PRODUCTS REPORT)Due to the newfound understanding of oral cancer risk, the dental professional should take seriously the options for insurance coverage from both the dental and medical insurer for the patient’s exam.

Dental professionals are a patient’s primary source of screening within the oral cavity; thus attention must be paid to the most common oral malignancy: squamous cell carcinoma. Historically such malignancies were attributed only to [Read more…]